Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

PDL 1 immunohistochemistry laboratory validation

Date

07 Oct 2016

Session

Joint Symposium ESMO-ESP: How to select patients for immunotherapy: The role of pathology

Presenters

Mogens Vyberg

Authors

M. Vyberg

Author affiliations

Institute Of Pathology, Aalborg University Hospital, 9000 - Aalborg/DK

More

Resources

Login to access the resources on OncologyPRO.

If you do not have an ESMO account, please create one for free.

Login

Resources from the same session

07 Oct 2016

PDL 1 Immunohistochemistry clinical validation with the example of thoracic tumours

Presenter: Solange Peters

Session: Joint Symposium ESMO-ESP: How to select patients for immunotherapy: The role of pathology

Resources:

Presentation

Webcast

07 Oct 2016

Introduction

Presenter: Peter Schirmacher

Session: Joint Symposium ESMO-ESP: How to select patients for immunotherapy: The role of pathology

Resources:

Presentation

Webcast

07 Oct 2016

Conclusions and clinical perspectives

Presenter: Rolf A. Stahel

Session: Joint Symposium ESMO-ESP: How to select patients for immunotherapy: The role of pathology

Resources:

Webcast

07 Oct 2016

Beyond immunohistochemistry

Presenter: Ian Cree

Session: Joint Symposium ESMO-ESP: How to select patients for immunotherapy: The role of pathology

Resources:

Presentation

Webcast